A detailed history of Raymond James & Associates transactions in Resmed Inc stock. As of the latest transaction made, Raymond James & Associates holds 13,231 shares of RMD stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,231
Previous 20,180 34.44%
Holding current value
$3.27 Million
Previous $3.86 Million 16.39%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$186.94 - $252.92 $1.3 Million - $1.76 Million
-6,949 Reduced 34.44%
13,231 $3.23 Million
Q2 2024

Jul 19, 2024

BUY
$173.83 - $220.63 $2.37 Million - $3.01 Million
13,633 Added 208.23%
20,180 $3.86 Million
Q1 2024

Apr 22, 2024

SELL
$165.79 - $198.03 $48,908 - $58,418
-295 Reduced 4.31%
6,547 $1.3 Million
Q4 2023

Jan 16, 2024

BUY
$134.65 - $174.81 $161,580 - $209,772
1,200 Added 21.27%
6,842 $1.18 Million
Q3 2023

Oct 24, 2023

SELL
$136.29 - $225.35 $2.18 Million - $3.61 Million
-16,028 Reduced 73.96%
5,642 $834,000
Q2 2023

Jul 25, 2023

BUY
$209.98 - $240.96 $396,442 - $454,932
1,888 Added 9.54%
21,670 $4.73 Million
Q1 2023

Apr 14, 2023

SELL
$205.07 - $236.53 $51,677 - $59,605
-252 Reduced 1.26%
19,782 $4.33 Million
Q4 2022

Feb 08, 2023

SELL
$205.77 - $233.97 $555,784 - $631,952
-2,701 Reduced 11.88%
20,034 $4.17 Million
Q3 2022

Oct 25, 2022

SELL
$212.32 - $243.58 $316,993 - $363,664
-1,493 Reduced 6.16%
22,735 $4.96 Million
Q2 2022

Aug 12, 2022

SELL
$191.41 - $252.08 $243,282 - $320,393
-1,271 Reduced 4.98%
24,228 $5.08 Million
Q1 2022

May 11, 2022

BUY
$216.12 - $261.47 $499,237 - $603,995
2,310 Added 9.96%
25,499 $6.18 Million
Q4 2021

Feb 08, 2022

SELL
$248.03 - $268.66 $615,610 - $666,814
-2,482 Reduced 9.67%
23,189 $6.04 Million
Q3 2021

Nov 02, 2021

SELL
$247.68 - $297.36 $609,045 - $731,208
-2,459 Reduced 8.74%
25,671 $6.77 Million
Q2 2021

Aug 11, 2021

SELL
$187.97 - $247.09 $1.56 Million - $2.05 Million
-8,290 Reduced 22.76%
28,130 $6.94 Million
Q1 2021

May 14, 2021

SELL
$179.46 - $222.28 $539,277 - $667,951
-3,005 Reduced 7.62%
36,420 $7.07 Million
Q4 2020

Feb 12, 2021

BUY
$167.5 - $220.59 $382,570 - $503,827
2,284 Added 6.15%
39,425 $8.38 Million
Q3 2020

Nov 04, 2020

BUY
$168.14 - $205.63 $203,449 - $248,812
1,210 Added 3.37%
37,141 $6.37 Million
Q2 2020

Jul 28, 2020

BUY
$142.29 - $192.0 $728,809 - $983,424
5,122 Added 16.63%
35,931 $6.9 Million
Q1 2020

Apr 21, 2020

BUY
$114.34 - $176.62 $1.01 Million - $1.56 Million
8,842 Added 40.25%
30,809 $4.54 Million
Q4 2019

Feb 12, 2020

SELL
$126.52 - $156.7 $20,749 - $25,698
-164 Reduced 0.74%
21,967 $3.4 Million
Q3 2019

Nov 07, 2019

SELL
$123.37 - $140.33 $481,513 - $547,707
-3,903 Reduced 14.99%
22,131 $2.99 Million
Q2 2019

Aug 06, 2019

BUY
$97.37 - $123.27 $1.83 Million - $2.32 Million
18,816 Added 260.68%
26,034 $3.18 Million
Q1 2019

May 06, 2019

SELL
$91.56 - $117.84 $801,607 - $1.03 Million
-8,755 Reduced 54.81%
7,218 $750,000
Q4 2018

Feb 11, 2019

BUY
$98.06 - $115.33 $211,907 - $249,228
2,161 Added 15.65%
15,973 $1.82 Million
Q3 2018

Nov 14, 2018

SELL
$103.52 - $115.55 $38,095 - $42,522
-368 Reduced 2.6%
13,812 $1.6 Million
Q2 2018

Aug 14, 2018

BUY
$93.62 - $107.93 $233,956 - $269,717
2,499 Added 21.39%
14,180 $1.47 Million
Q1 2018

May 14, 2018

SELL
$85.53 - $102.82 $23,178 - $27,864
-271 Reduced 2.27%
11,681 $1.15 Million
Q4 2017

Feb 14, 2018

BUY
$76.14 - $86.44 $910,025 - $1.03 Million
11,952 New
11,952 $1.01 Million
Q3 2017

Nov 13, 2017

SELL
$76.11 - $77.2 $196,059 - $198,867
-2,576 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
2,576
2,576 $201,000

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $36.2B
More about RMD
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.